氨甲环酸在面颈部除皱术中安全性与有效性的系统评价
该系统评价遵循PRISMA指南,检索4个数据库至2024年10月4日,纳入10篇文章、共592例接受面或颈部除皱术并给予氨甲环酸的患者,其中534例(90%)为女性,平均年龄62.0岁。氨甲环酸在减少术中出血、术后瘀斑、水肿和引流量方面显示出有希望的结果,但部分伤口相关并发症被报告,皮肤瓣并发症无统计学显著性(p > 0.05)。
要点
- 氨甲环酸可减少面颈部除皱术中的术中出血和手术时间。
- 6项研究中有4项显示氨甲环酸降低血肿发生率。
- 氨甲环酸未增加全身并发症,但报告了部分伤口相关并发症。
核心结论
- 氨甲环酸在面部手术中通过减少术中出血和时间、术后瘀斑、水肿及引流量显示出有希望的结果。
- 尽管氨甲环酸未增加全身并发症,但报告了部分伤口相关并发症。
研究设计与样本
- 遵循PRISMA指南的系统评价,检索4个数据库至2024年10月4日。
- 共纳入10篇文章,592例患者接受面或颈部除皱术并给予氨甲环酸,其中534例(90%)为女性,平均年龄62.0岁。
主要发现
- 氨甲环酸剂量范围为局部1至25 mg/mL和静脉1 g,给药途径包括局部(4项研究)、局部注射(5项研究)、与肿胀液混合(3项研究)或静脉(4项研究)。
- 3项研究显示氨甲环酸减少术中出血的证据。
- 6项研究中有4项显示氨甲环酸降低血肿发生率。
- 报告了瘀斑显著减少和术后瘀斑持续时间缩短。
- 皮肤瓣并发症被报告,但均无统计学显著性(p > 0.05)。
关键数值与推荐
- 氨甲环酸局部剂量范围为1至25 mg/mL,静脉剂量为1 g。
- 皮肤瓣并发症无统计学显著性(p > 0.05)。
- 术后水肿减少在2项研究中的1项有统计学显著性(p < 0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Tranexamic acid (TXA) has been used in various surgical settings to reduce bleeding and improve patient outcomes; however, its efficacy in face and neck lift is underexplored. METHODS: Following the PRISMA guidelines, this systematic review identified articles from 4 databases up to October 4, 2024, aiming to assess the efficacy of TXA in reducing the complications in patients undergoing face and/or neck lift. RESULTS: Ten articles were included. A total of 592 patients underwent either face or neck lift with TXA administration, among them 534 (90%) were women with a mean age of 62.0 years. TXA dosage ranged from 1 to 25 mg/mL topically and 1 g IV and was administered topically (4 studies), with local injection (5 studies), mixed with tumescence solution (3 studies), or intravenously (4 studies). Three studies showed evidence of reduced intraoperative blood loss with TXA. TXA reduced hematoma incidence in 4 of the 6 studies. Significant reductions in ecchymosis and shorter postoperative ecchymosis duration were reported. Skin flap complications were reported, but none were statistically significant (p > 0.05). TXA significantly reduced postoperative edema in 1 of 2 studies (p < 0.05). Procedure time was either unchanged or reduced. Drainage output and days before drain removal was reduced with TXA in 5 studies. There was no difference in the incidence of infection between groups. CONCLUSION: TXA demonstrated promising results in facial surgery by reducing intraoperative bleeding and time, postoperative ecchymosis, edema, and drain output. Although TXA did not increase systemic complications, some wound-related complications were reported.
引用
- ElAbd R, Richa Y, Pu L, et al. Evaluation of the safety and efficacy of tranexamic acid use in face and neck lift surgery: A systematic review. J Plast Reconstr Aesthet Surg. 2025. PMID: 40168920. doi:10.1016/j.bjps.2025.03.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。